| Bioactivity | Goralatide TFA is an inhibitor of cell cycle progression. Goralatide TFA enhances selectivity of hyperthermic purging of human progenitor cells. Goralatide TFA has the potential for the research of leukemia[1]. | ||||||
| Name | Goralatide TFA | ||||||
| CAS | 1796568-94-9 | ||||||
| Shortening | Ac-SDKP | ||||||
| Formula | C22H34F3N5O11 | ||||||
| Molar Mass | 601.53 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Goralatide TFA
CAS: 1796568-94-9 F: C22H34F3N5O11 W: 601.53
Goralatide TFA is an inhibitor of cell cycle progression. Goralatide TFA enhances selectivity of hyperthermic purging of
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.